These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6255035)

  • 1. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.
    Meyers JD; Flournoy N; Thomas ED
    J Infect Dis; 1980 Sep; 142(3):338-46. PubMed ID: 6255035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regeneration of humoral immunity to herpes simplex virus following T-cell-depleted allogeneic bone marrow transplantation.
    Wimperis JZ; Berry NJ; Prentice HG; Lever A; Griffiths PD; Brenner MK
    J Med Virol; 1987 Sep; 23(1):93-9. PubMed ID: 2824679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.
    Meyers JD; Flournoy N; Thomas ED
    J Infect Dis; 1980 Dec; 142(6):816-24. PubMed ID: 6257800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
    Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
    Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.
    Oakes JE
    Infect Immun; 1975 Jul; 12(1):166-72. PubMed ID: 166926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
    Wade JC; Day LM; Crowley JJ; Meyers JD
    J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
    Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.
    Burchett SK; Corey L; Mohan KM; Westall J; Ashley R; Wilson CB
    J Infect Dis; 1992 May; 165(5):813-8. PubMed ID: 1314868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy.
    Pass RF; Dworsky ME; Whitley RJ; August AM; Stagno S; Alford CA
    Infect Immun; 1981 Oct; 34(1):166-70. PubMed ID: 6271679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation.
    Pass RF; Whitley RJ; Whelchel JD; Diethelm AG; Reynolds DW; Alford CA
    J Infect Dis; 1979 Oct; 140(4):487-92. PubMed ID: 390063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity to herpes virus type-1 in patients with recurrent corneal herpes simplex.
    Hammer H; Dobozy A
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):161-6. PubMed ID: 6249065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of indomethacin on the in vitro lymphocyte transformation response to herpes simplex virus antigen and phytohemagglutinin after marrow transplant.
    Meyers JD; Wade JC; Day LM
    J Infect Dis; 1982 Aug; 146(2):289. PubMed ID: 6286791
    [No Abstract]   [Full Text] [Related]  

  • 16. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus (HSV) colitis in a bone marrow transplant recipient.
    Naik HR; Chandrasekar PH
    Bone Marrow Transplant; 1996 Feb; 17(2):285-6. PubMed ID: 8640181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection.
    Schubert MM; Peterson DE; Flournoy N; Meyers JD; Truelove EL
    Oral Surg Oral Med Oral Pathol; 1990 Sep; 70(3):286-93. PubMed ID: 2170891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible transmission of herpes simplex virus by organ transplantation.
    Goodman JL
    Transplantation; 1989 Apr; 47(4):609-13. PubMed ID: 2539664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
    Smith JW; Torres JE; Holmquist ND
    Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.